Noninvasive bioluminescence imaging of olfactory ensheathing glia and Schwann cells following transplantation into the lesioned rat spinal cord

Cell Transplantation

Volumn 21, Issue 9, 2012, Pages 1853-1865

  Roet, Kasper C D ^a   Eggers, Ruben ^a   Verhaagen, Joost ^a,b  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Bioluminescence; Luciferase; Noninvasive; Olfactory ensheathing cell; Schwann cell; Spinal cord; Survival

Indexed keywords

GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CELL SURVIVAL; CELL TRANSPLANTATION; CELL TYPE; FEMALE; HISTOLOGY; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OLFACTORY ENSHEATHING CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURIFICATION; RAT; SCHWANN CELL; SCIATIC NERVE; SPINAL CORD; SPINAL CORD LESION;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GREEN FLUORESCENT PROTEINS; LUMINESCENT MEASUREMENTS; NEUROGLIA; OLFACTORY BULB; RATS; SCHWANN CELLS; SPINAL CORD INJURIES;

RATTUS;

EID: 84869782636     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X627471     Document Type: Article

References (91)

1. Akens, M. K.; Hardisty, M. R.; Wilson, B. C.; 1. Schwock, J.; Whyne, C. M.; Burch, S.; Yee, A. J. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin). Breast Cancer Res. Treat. 119:325-333; 2010.
2. Alexander, J. K.; Popovich, P. G. Neuroinflammation in spinal cord injury: Therapeutic targets for neuroprotection and regeneration. Prog. Brain Res. 175:125-137; 2009.
3. Austin, P. J.; Moalem-Taylor, G. The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines. J. Neuroimmunol. 229:26-50; 2010.
4. Barakat, D. J.; Gaglani, S. M.; Neravetla, S. R.; Sanchez, A. R.; Andrade, C. M.; Pressman, Y.; Puzis, R.; Garg, M. S.; Bunge, M. B.; Pearse, D. D. Survival, integration, and axon growth support of glia transplanted into the chronically contused spinal cord. Cell Transplant. 14:225-240; 2005.
5. Barnett, S. C.; Riddell, J. S. Olfactory ensheathing cell transplantation as a strategy for spinal cord repair-what can it achieve? Nat. Clin. Pract. Neurol. 3:152-161; 2007.
6. Blakemore, W. F.; Crang, A. J. The use of cultured autologous Schwann cells to remyelinate areas of persistent demyelination in the central nervous system. J. Neurol. Sci. 70:207-223; 1985.
7. Blesch, A.; Tuszynski, M. H. Transient growth factor delivery sustains regenerated axons after spinal cord injury. J. Neurosci. 27:10535-10545; 2007.
8. Blits, B.; Dijkhuizen, P. A.; Boer, G. J.; Verhaagen, J. Intercostal nerve implants transduced with an adenoviral vector encoding neurotrophin-3 promote regrowth of injured rat corticospinal tract fibers and improve hindlimb function. Exp. Neurol. 164:25-37; 2000.
9. Bregman, B. S.; Coumans, J. V.; Dai, H. N.; Kuhn, P. L.; Lynskey, J.; McAtee, M.; Sandhu, F. Transplants and neurotrophic factors increase regeneration and recovery of function after spinal cord injury. Prog. Brain Res. 137:257-273; 2002.
10. Bunge, M. B. Novel combination strategies to repair the injured mammalian spinal cord. J. Spinal Cord Med. 31:262-269; 2008.
11. Burch, S.; Bisland, S. K.; Bogaards, A.; Yee, A. J.; Whyne, C. M.; Finkelstein, J. A.; Wilson, B. C. Photodynamic therapy for the treatment of vertebral metastases in a rat model of human breast carcinoma. J. Orthop. Res. 23:995-1003; 2005.
12. Cejas, P. J.; Martinez, M.; Karmally, S.; McKillop, M.; McKillop, J.; Plunkett, J. A.; Oudega, M.; Eaton, M. J. Lumbar transplant of neurons genetically modified to secrete brain-derived neurotrophic factor attenuates allodynia and hyperalgesia after sciatic nerve constriction. Pain 86:195-210; 2000.
13. Chen, A.; Xu, X. M.; Kleitman, N.; Bunge, M. B. Methylprednisolone administration improves axonal regeneration into Schwann cell grafts in transected adult rat thoracic spinal cord. Exp. Neurol. 138:261-276; 1996.
14. Chernykh, E. R.; Stupak, V. V.; Muradov, G. M.; Sizikov, M. Y.; Shevela, E. Y.; Leplina, O. Y.; Tikhonova, M. A.; Kulagin, A. D.; Lisukov, I. A.; Ostanin, A. A.; Kozlov, V. A. Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients. Bull. Exp. Biol. Med. 143:543-547; 2007.
15. Dull, T.; Zufferey, R.; Kelly, M.; Mandel, R. J.; Nguyen, M.; Trono, D.; Naldini, L. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72:8463-8471; 1998.
16. Fairless, R.; Barnett, S. C. Olfactory ensheathing cells: Their role in central nervous system repair. Int. J. Biochem. Cell Biol. 37:693-699; 2005.
17. Feron, F.; Perry, C.; Cochrane, J.; Licina, P.; Nowitzke, A.; Urquhart, S.; Geraghty, T.; Mackay-Sim, A. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain 128:2951-2960; 2005.
18. Franssen, E. H.; de Bree, F. M.; Verhaagen, J. Olfactory ensheathing glia: Their contribution to primary olfactory nervous system regeneration and their regenerative potential following transplantation into the injured spinal cord. Brain Res. Rev. 56:236-258; 2007.
19. Franssen, E. H.; Roet, K. C.; de Bree, F. M.; Verhaagen, J. Olfactory ensheathing glia and Schwann cells exhibit a distinct interaction behavior with meningeal cells. J. Neurosci. Res. 87:1556-1564; 2009.
20. Gal, P.; Kravcukova, P.; Mokry, M.; Kluchova, D. Chemokines as possible targets in modulation of the secondary damage after acute spinal cord injury: A review. Cell. Mol. Neurobiol. 29:1025-1035; 2009.
21. Geuze, R. E.; Prins, H. J.; Oner, F. C.; van der Helm, Y. J.; Schuijff, L. S.; Martens, A. C.; Kruyt, M. C.; Alblas, J.; Dhert, W. J. Luciferase labeling for multipotent stromal cell tracking in spinal fusion versus ectopic bone tissue engineering in mice and rats. Tissue Eng. Part A 16:3343-3351; 2010.
22. Golden, K. L.; Pearse, D. D.; Blits, B.; Garg, M. S.; Oudega, M.; Wood, P. M.; Bunge, M. B. Transduced Schwann cells promote axon growth and myelination after spinal cord injury. Exp. Neurol. 207:203-217; 2007.
23. Grill, R. J.; Blesch, A.; Tuszynski, M. H. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp. Neurol. 148:444-452; 1997.
24. Hendriks, W. T.; Eggers, R.; Verhaagen, J.; Boer, G. J. Gene transfer to the spinal cord neural scar with lentiviral vectors: Predominant transgene expression in astrocytes but not in meningeal cells. J. Neurosci. Res. 85:3041-3052; 2007.
25. Hill, C. E.; Guller, Y.; Raffa, S. J.; Hurtado, A.; Bunge, M. B. A calpain inhibitor enhances the survival of schwann cells in vitro and after transplantation into the injured spinal cord. J. Neurotrauma 27:1685-1695; 2010.
26. Hill, C. E.; Hurtado, A.; Blits, B.; Bahr, B. A.; Wood, P. M.; Bartlett, B. M.; Oudega, M. Early necrosis and apoptosis of Schwann cells transplanted into the injured rat spinal cord. Eur. J. Neurosci. 26:1433-1445; 2007.
27. Hill, C. E.; Moon, L. D.; Wood, P. M.; Bunge, M. B. Labeled Schwann cell transplantation: Cell loss, host Schwann cell replacement, and strategies to enhance survival. Glia 53:338-343; 2006.
28. Hu, Y.; Arulpragasam, A.; Plant, G. W.; Hendriks, W. T.; Cui, Q.; Harvey, A. R. The importance of transgene and cell type on the regeneration of adult retinal ganglion cell axons within reconstituted bridging grafts. Exp. Neurol. 207:314-328; 2007.
29. Hu, Y.; Leaver, S. G.; Plant, G. W.; Hendriks, W. T.; Niclou, S. P.; Verhaagen, J.; Harvey, A. R.; Cui, Q. Lentiviralmediated transfer of CNTF to schwann cells within reconstructed peripheral nerve grafts enhances adult retinal ganglion cell survival and axonal regeneration. Mol. Ther. 11:906-915; 2005.
30. Imaizumi, T.; Lankford, K. L.; Kocsis, J. D. Transplantation of olfactory ensheathing cells or Schwann cells restores rapid and secure conduction across the transected spinal cord. Brain Res. 854:70-78; 2000.
31. Imaizumi, T.; Lankford, K. L.; Waxman, S. G.; Greer, C. A.; Kocsis, J. D. Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord. J. Neurosci. 18:6176-6185; 1998.
32. Imperato-Kalmar, E. L.; McKinney, R. A.; Schnell, L.; Rubin, B. P.; Schwab, M. E. Local changes in vascular architecture following partial spinal cord lesion in the rat. Exp. Neurol. 145:322-328; 1997.
33. Jain, K. K. Cell therapy for CNS trauma. Mol. Biotechnol. 42:367-376; 2009.
34. Keane, R. W.; Davis, A. R.; Dietrich, W. D. Inflammatory and apoptotic signaling after spinal cord injury. J. Neurotrauma 23:335-344; 2006.
35. Keyaerts, M.; Verschueren, J.; Bos, T. J.; Tchouate-Gainkam, L. O.; Peleman, C.; Breckpot, K.; Vanhove, C.; Caveliers, V.; Bossuyt, A.; Lahoutte, T. Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D-luciferin: Effect on intensity, time kinetics and repeatability of photon emission. Eur. J. Nucl. Med. Mol. Imaging 35:999-1007; 2008.
36. Kobayashi, S.; Miura, M.; Asou, H.; Inoue, H. K.; Ohye, C.; Uyemura, K. Grafts of genetically modified fibroblasts expressing neural cell adhesion molecule L1 into transected spinal cord of adult rats. Neurosci. Lett. 188:191-194; 1995.
37. Kuhlengel, K. R.; Bunge, M. B.; Bunge, R. P.; Burton, H. Implantation of cultured sensory neurons and Schwann cells into lesioned neonatal rat spinal cord. II. Implant characteristics and examination of corticospinal tract growth. J. Comp. Neurol. 293:74-91; 1990.
38. Kumar, A. A.; Kumar, S. R.; Narayanan, R.; Arul, K.; Baskaran, M. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data. Exp. Clin. Transplant. 7:241-248; 2009.
39. Lee, I. H.; Bulte, J. W.; Schweinhardt, P.; Douglas, T.; Trifunovski, A.; Hofstetter, C.; Olson, L.; Spenger, C. In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord. Exp. Neurol. 187:509-516; 2004.
40. Leo, B. M.; Li, X.; Balian, G.; Anderson, D. G. In vivo bioluminescent imaging of virus-mediated gene transfer and transduced cell transplantation in the intervertebral disc. Spine 29:838-844; 2004.
41. Li, Y.; Field, P. M.; Raisman, G. Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science 277:2000-2002; 1997.
42. Li, Y.; Raisman, G. Schwann cells induce sprouting in motor and sensory axons in the adult rat spinal cord. J. Neurosci. 14:4050-4063; 1994.
43. Li, Y.; Yu, H. L.; Chen, L. F.; Duan, C. X.; Zhang, J. Y.; Li, B. C. Survival and number of olfactory ensheathing cells transplanted in contused spinal cord of rats. Chin. J. Traumatol. 13:356-361; 2010.
44. Lima, C.; Pratas-Vital, J.; Escada, P.; Hasse-Ferreira, A.; Capucho, C.; Peduzzi, J. D. Olfactory mucosa autografts in human spinal cord injury: A pilot clinical study. J. Spinal Cord Med. 29:191-203; 2006.
45. Lindsay, S. L.; Riddell, J. S.; Barnett, S. C. Olfactory mucosa for transplant-mediated repair: A complex tissue for a complex injury? Glia 58:125-134; 2010.
46. Liu, Y.; Kim, D.; Himes, B. T.; Chow, S. Y.; Schallert, T.; Murray, M.; Tessler, A.; Fischer, I. Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J. Neurosci. 19:4370-4387; 1999.
47. Loane, D. J.; Byrnes, K. R. Role of microglia in neurotrauma. Neurotherapeutics 7:366-377; 2010.
48. Lu, P.; Jones, L. L.; Tuszynski, M. H. Axon regeneration through scars and into sites of chronic spinal cord injury. Exp. Neurol. 203:8-21; 2007.
49. Luo, J.; Bo, X.; Wu, D.; Yeh, J.; Richardson, P. M.; Zhang, Y. Promoting survival, migration, and integration of transplanted Schwann cells by over-expressing polysialic acid. Glia 59:424-434; 2011.
50. Ma, Y. H.; Zhang, Y.; Cao, L.; Su, J. C.; Wang, Z. W.; Xu, A. B.; Zhang, S. C. Effect of neurotrophin-3 genetically modified olfactory ensheathing cells transplantation on spinal cord injury. Cell Transplant. 19:167-177; 2010.
51. Mackay-Sim, A.; Chuah, M. I. Neurotrophic factors in the primary olfactory pathway. Prog. Neurobiol. 62:527-559; 2000.
52. Mackay-Sim, A.; Feron, F.; Cochrane, J.; Bassingthwaighte, L.; Bayliss, C.; Davies, W.; Fronek, P.; Gray, C.; Kerr, G.; Licina, P.; Nowitzke, A.; Perry, C.; Silburn, P. A.; Urquhart, S.; Geraghty, T. Autologous olfactory ensheathing cell transplantation in human paraplegia: A 3-year clinical trial. Brain 131:2376-2386; 2008.
53. Mayor, S. First patient enters trial to test safety of stem cells in spinal injury. BMJ 341:c5724; 2010.
54. Morrissey, T. K.; Kleitman, N.; Bunge, R. P. Isolation and functional characterization of Schwann cells derived from adult peripheral nerve. J. Neurosci. 11:2433-2442; 1991.
55. Nakahara, Y.; Gage, F. H.; Tuszynski, M. H. Grafts of fibroblasts genetically modified to secrete NGF, BDNF, NT-3, or basic FGF elicit differential responses in the adult spinal cord. Cell Transplant. 5:191-204; 1996.
56. Naldini, L.; Blomer, U.; Gallay, P.; Ory, D.; Mulligan, R.; Gage, F. H.; Verma, I. M.; Trono, D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267; 1996.
57. Noble, L. J.; Wrathall, J. R. Distribution and time course of protein extravasation in the rat spinal cord after contusive injury. Brain Res. 482:57-66; 1989.
58. Okada, S.; Ishii, K.; Yamane, J.; Iwanami, A.; Ikegami, T.; Katoh, H.; Iwamoto, Y.; Nakamura, M.; Miyoshi, H.; Okano, H. J.; Contag, C. H.; Toyama, Y.; Okano, H. In vivo imaging of engrafted neural stem cells: Its application in evaluating the optimal timing of transplantation for spinal cord injury. FASEB J. 19:1839-1841; 2005.
59. Olsson, Y.; Sharma, H. S.; Pettersson, C. A. Effects of p-chlorophenylalanine on microvascular permeability changes in spinal cord trauma. An experimental study in the rat using 131I-sodium and lanthanum tracers. Acta Neuropathol. 79:595-603; 1990.
60. Oudega, M. Schwann cell and olfactory ensheathing cell implantation for repair of the contused spinal cord. Acta Physiol. 189:181-189; 2007.
61. Oudega, M.; Xu, X. M. Schwann cell transplantation for repair of the adult spinal cord. J. Neurotrauma 23:453-467; 2006.
62. Paino, C. L.; Fernandez-Valle, C.; Bates, M. L.; Bunge, M. B. Regrowth of axons in lesioned adult rat spinal cord: Promotion by implants of cultured Schwann cells. J. Neurocytol. 23:433-452; 1994.
63. Patel, V.; Joseph, G.; Patel, A.; Patel, S.; Bustin, D.; Mawson, D.; Tuesta, L. M.; Puentes, R.; Ghosh, M.; Pearse, D. D. Suspension matrices for improved Schwann-cell survival after implantation into the injured rat spinal cord. J. Neurotrauma 27:789-801; 2010.
64. Pearse, D. D.; Sanchez, A. R.; Pereira, F. C.; Andrade, C. M.; Puzis, R.; Pressman, Y.; Golden, K.; Kitay, B. M.; Blits, B.; Wood, P. M.; Bunge, M. B. Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: Survival, migration, axon association, and functional recovery. Glia 55:976-1000; 2007.
65. Popovich, P. G.; Horner, P. J.; Mullin, B. B.; Stokes, B. T. A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp. Neurol. 142:258-275; 1996.
66. Radtke, C.; Sasaki, M.; Lankford, K. L.; Vogt, P. M.; Kocsis, J. D. Potential of olfactory ensheathing cells for cell-based therapy in spinal cord injury. J. Rehabil. Res. Dev. 45:141-151; 2008.
67. Raisman, G.; Li, Y. Repair of neural pathways by olfactory ensheathing cells. Nat. Rev. Neurosci. 8:312-319; 2007.
68. Ramon-Cueto, A.; Plant, G. W.; Avila, J.; Bunge, M. B. Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J. Neurosci. 18:3803-3815; 1998.
69. Richter, M. W.; Roskams, A. J. Olfactory ensheathing cell transplantation following spinal cord injury: Hype or hope? Exp. Neurol. 209:353-367; 2008.
70. Ronsyn, M. W.; Berneman, Z. N.; Van Tendeloo, V. F.; Jorens, P. G.; Ponsaerts, P. Can cell therapy heal a spinal cord injury? Spinal Cord 46:532-539; 2008.
71. Rooney, G. E.; McMahon, S. S.; Ritter, T.; Garcia, Y.; Moran, C.; Madigan, N. N.; Flugel, A.; Dockery, P.; O'Brien, T.; Howard, L.; Windebank, A. J.; Barry, F. P. Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cells. Tissue Eng. Part A 15:3049-3059; 2009.
72. Ruitenberg, M. J.; Levison, D. B.; Lee, S. V.; Verhaagen, J.; Harvey, A. R.; Plant, G. W. NT-3 expression from engineered olfactory ensheathing glia promotes spinal sparing and regeneration. Brain 128:839-853; 2005.
73. Ruitenberg, M. J.; Plant, G. W.; Christensen, C. L.; Blits, B.; Niclou, S. P.; Harvey, A. R.; Boer, G. J.; Verhaagen, J. Viral vector-mediated gene expression in olfactory ensheathing glia implants in the lesioned rat spinal cord. Gene Ther. 9:135-146; 2002.
74. Ruitenberg, M. J.; Plant, G. W.; Hamers, F. P.; Wortel, ortel, J.; Blits, B.; Dijkhuizen, P. A.; Gispen, W. H.; Boer, G. J.; Verhaagen, J. Ex vivo adenoviral vector-mediated neurotrophin gene transfer to olfactory ensheathing glia: Effects on rubrospinal tract regeneration, lesion size, and functional recovery after implantation in the injured rat spinal cord. J. Neurosci. 23:7045-7058; 2003.
75. Ruitenberg, M. J.; Vukovic, J.; Sarich, J.; Busfield, S. J.; Plant, G. W. Olfactory ensheathing cells: Characteristics, genetic engineering, and therapeutic potential. J. Neurotrauma 23:468-478; 2006.
76. Saberi, H.; Moshayedi, P.; Aghayan, H. R.; Arjmand, B.; Hosseini, S. K.; Emami-Razavi, S. H.; Rahimi-Movaghar, V.; Raza, M.; Firouzi, M. Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: An interim report on safety considerations and possible outcomes. Neurosci. Lett. 443:46-50; 2008.
77. Sahni, V.; Kessler, J. A. Stem cell therapies for spinal cord injury. Nat. Rev. Neurol. 6:363-372; 2010.
78. Saito, F.; Nakatani, T.; Iwase, M.; Maeda, Y.; Hirakawa, A.; Murao, Y.; Suzuki, Y.; Onodera, R.; Fukushima, M.; Ide, C. Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: The first clinical trial case report. J. Trauma 64:53-59; 2008.
79. Takahashi, Y.; Tsuji, O.; Kumagai, G.; Hara, C. M.; Okano, H. J.; Miyawaki, A.; Toyama, Y.; Okano, H.; Nakamura, M. Comparative study of methods for administering neural stem/progenitor cells to treat spinal cord injury in mice. Cell Transplant. 20:727-739; 2011.
80. Tetzlaff, W.; Okon, E. B.; Karimi-Abdolrezaee, S.; Hill, C. E.; Sparling, J. S.; Plemel, J. R.; Plunet, W. T.; Tsai, E. C.; Baptiste, D.; Smithson, L. J.; Kawaja, M. D.; Fehlings, M. G.; Kwon, B. K. A Systematic review of cellular transplantation therapies for spinal cord injury. J. Neurotrauma 28:1611-1682; 2011.
81. Thuret, S.; Moon, L. D.; Gage, F. H. Therapeutic interventions after spinal cord injury. Nat. Rev. Neurosci. 7:628-643; 2006.
82. Trivedi, A.; Olivas, A. D.; Noble-Haeusslein, L. J. Inflammation and spinal cord injury: Infiltrating leukocytes as determinants of injury and repair processes. Clin. Neurosci. Res. 6:283-292; 2006.
83. Tuszynski, M. H.; Peterson, D. A.; Ray, J.; Baird, A.; Nakahara, Y.; Gage, F. H. Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp. Neurol. 126:1-14; 1994.
84. Tuszynski, M. H.; Weidner, N.; McCormack, M.; Miller, I.; Powell, H.; Conner, J. Grafts of genetically modified Schwann cells to the spinal cord: Survival, axon growth, and myelination. Cell Transplant. 7:187-196; 1998.
85. Vaquero, J.; Zurita, M. Bone marrow stromal cells for spinal cord repair: A challenge for contemporary neurobiology. Histol. Histopathol. 24:107-116; 2009.
86. Webber, D. J.; Bradbury, E. J.; McMahon, S. B.; Minger, S. L. Transplanted neural progenitor cells survive and differentiate but achieve limited functional recovery in the lesioned adult rat spinal cord. Regen. Med. 2:929-945; 2007.
87. Wewetzer, K.; Radtke, C.; Kocsis, J.; Baumgartner, W. Species-specific control of cellular proliferation and the impact of large animal models for the use of olfactory ensheathing cells and Schwann cells in spinal cord repair. Exp. Neurol. 2010.
88. Willerth, S. M.; Sakiyama-Elbert, S. E. Cell therapy for spinal cord regeneration. Adv. Drug Deliv. Rev. 60:263-276; 2008.
89. Yoon, S. H.; Shim, Y. S.; Park, Y. H.; Chung, J. K.; Nam, J. H.; Kim, M. O.; Park, H. C.; Park, S. R.; Min, B. H.; Kim, E. Y.; Choi, B. H.; Park, H.; Ha, Y. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells 25:2066-2073; 2007.
90. Zhang, W.; Yan, Q.; Zeng, Y. S.; Zhang, X. B.; Xiong, Y.; Wang, J. M.; Chen, S. J.; Li, Y.; Bruce, I. C.; Wu, W. Implantation of adult bone marrow-derived mesenchymal stem cells transfected with the neurotrophin-3 gene and pretreated with retinoic acid in completely transected spinal cord. Brain Res. 1359:256-271; 2010.
91. Zhang, X.; Zeng, Y.; Zhang, W.; Wang, J.; Wu, J.; Li, J. Co-transplantation of neural stem cells and NT-3-overexpressing Schwann cells in transected spinal cord. J. Neurotrauma 24:1863-1877; 2007.